Buprenorphine
Chronic Lower Back Pain
Braeburn PharmaceuticalsSmall moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Chronic Lower Back Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
asp7962 Astellas Pharma Europe B.V. | Phase 2 | B |
Naproxen Astellas Pharma Europe B.V. | Phase 2 | B |
Umbilical Cord Blood-Derived Stem Cells Adia Med of Winter Park LLC | Phase 1 | CC |
Exosomes Adia Med of Winter Park LLC | Phase 1 | CC |
Same molecule, other indications
Buprenorphine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →